Publications by authors named "Remi Sumiyoshi"

Claim this Profile
D
Diagnostic challenges of the idiopathic plasmacytic lymphadenopathy (IPL) subtype of idiopathic multicentric Castleman disease (iMCD): Factors to differentiate from IgG4-related disease.
Asami Nishikori, Midori Filiz Nishimura, David C Fajgenbaum, Yoshito Nishimura, Kanna Maehama, Remi Sumiyoshi

J Clin Pathol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment outcomes stratified by interferon profile and autoantibodies in rheumatoid arthritis.
Shoichi Fukui, Tohru Michitsuji, Yushiro Endo, Ayako Nishino, Kaori Furukawa, Remi Sumiyoshi

J Autoimmun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential link between COVID-19 infection/vaccination and the onsets of TAFRO syndrome and idiopathic multicentric castleman disease.
Masataka Umeda, Lamiaa Mohamed, Ayaka Umetsu, Mizuna Otsuka, Yushiro Endo, Remi Sumiyoshi

Immunol Lett· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II investigator-initiated, continuation trial of 5-aminolevulinic acid hydrochloride/sodium ferrous citrate (5-ALA-HCl/SFC) for patients with adult-onset Still's disease (AOSD) refractory to glucocorticoids.
Remi Sumiyoshi, Tomohiro Koga, Osamu Kamisawa, Shimpei Morimoto, Naoki Hosogaya

Drug Discov Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement of Lymphedema in IgG4-Related Disease with Oral Glucocorticoid Therapy.
Yuta Matsushita, Masataka Umeda, Hirokazu Kurohama, Tomoki Origuchi, Kanako Kojima, Remi Sumiyoshi

Intern Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Placebo-Controlled Exploratory Trial of Sirolimus for Tocilizumab-Resistant Idiopathic Multicentric Castleman Disease: Early Termination and Long-Term Extension Results Based on Descriptive Results From Two Patients.
Tomohiro Koga, Remi Sumiyoshi, Toshimasa Shimizu, Naoki Hosogaya, Chizu Fukushima

Cureus· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morphological and quantitative CT features of anterior mediastinal lesions in TAFRO syndrome and idiopathic multicentric Castleman disease.
Lamiaa Mohamed, Masataka Umeda, Shin Tsutsui, Ryo Toya, Ayaka Umetsu, Remi Sumiyoshi

Front Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of musculoskeletal ultrasound findings and cytokines/growth factors in glucocorticoid-resistant polymyalgia rheumatica.
Tomoki Origuchi, Masataka Umeda, Shoichi Fukui, Kaori Furukawa, Toshimasa Shimizu, Remi Sumiyoshi

Immunol Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Consensus Histopathological Criteria for Subtyping Idiopathic Multicentric Castleman Disease Based on Machine Learning Analysis.
Midori Filiz Nishimura, Tomoka Haratake, Yoshito Nishimura, Asami Nishikori, Remi Sumiyoshi

Am J Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase-II Investigator-Initiated Randomized, Double-Blind, Parallel-Group Clinical Trial of 5-Aminolevulinic Acid Hydrochloride/Sodium Ferrous Citrate (5-ALA-HCl/SFC) for Patients With Adult-Onset Still's Disease (AOSD) Refractory to Corticosteroids.
Remi Sumiyoshi, Tomohiro Koga, Osamu Kamisawa, Shimpei Morimoto, Naoki Hosogaya

Cureus· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Clinical Diversity of Castleman Disease and TAFRO Syndrome: A Japanese Multicenter Study on Lymph Node Distribution Patterns.
Mizuna Otsuka, Tomohiro Koga, Remi Sumiyoshi, Shoichi Fukui, Yuko Kaneko

Am J Hematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of etanercept biosimilar switching from etanercept reference product, using ultrasound and clinical data in outcomes of real world therapy (ESCORT-NGSK Study).
Remi Sumiyoshi, Shin-Ya Kawashiri, Toshimasa Shimizu, Tomohiro Koga, Rieko Kiya

Drug Discov Ther· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Etanercept Biosimilar Initiating for Etanercept-Naive Patients, Using Ultrasound, Clinical, and Biomarker Assessments in Outcomes of Real-World Therapy (ENPORT-NGSK Study): An Interventional, Multicenter, Open-Label, Single-Arm Clinical Trial.
Remi Sumiyoshi, Shin-Ya Kawashiri, Toshimasa Shimizu, Tomohiro Koga, Rieko Kiya

J Clin Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase Ib Investigator-Initiated Trial of Filgotinib in Patients With Idiopathic Multicentric Castleman Disease.
Shoichi Fukui, Remi Sumiyoshi, Tomohiro Koga, Naoki Hosogaya, Sawana Narita

Cureus· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of Serum Cytokines and Chemokines in Patients With Idiopathic Multicentric Castleman Disease: From a Phase Ib Investigator-Initiated Trial of Filgotinib.
Shoichi Fukui, Remi Sumiyoshi, Tomohiro Koga, Naoki Hosogaya, Sawana Narita

Cureus· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct clinical outcomes based on multiple serum cytokine and chemokine profiles rather than autoantibody profiles and ultrasound findings in rheumatoid arthritis: a prospective ultrasound cohort study.
Shoichi Fukui, Tohru Michitsuji, Yushiro Endo, Ayako Nishino, Kaori Furukawa, Remi Sumiyoshi

RMD Open· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment of systemic lupus erythematosus with residual disease activity by switching from belimumab to anifrolumab.
Masataka Umeda, Kanako Kojima, Toru Michitsuji, Yoshika Tsuji, Toshimasa Shimizu, Remi Sumiyoshi

Mod Rheumatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influences of advanced age in rheumatoid arthritis: A multicentre ultrasonography cohort study.
Chieko Kawahara, Shoichi Fukui, Tohru Michitsuji, Ayako Nishino, Yushiro Endo, Remi Sumiyoshi

Mod Rheumatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Hearing Impairment of Granulomatosis with Polyangiitis Treated with Rituximab and Avacopan without Glucocorticoids.
Aya Okubo, Shoichi Fukui, Mai Tanigawa, Kanako Kojima, Remi Sumiyoshi

Intern Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers and Signaling Pathways Implicated in the Pathogenesis of Idiopathic Multicentric Castleman Disease/Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis, Renal Insufficiency, and Organomegaly (TAFRO) Syndrome.
Remi Sumiyoshi, Tomohiro Koga, Atsushi Kawakami

Biomedicines· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of glucocorticoid use on the outcomes of rheumatoid arthritis in a multicenter ultrasound cohort study.
Fumiaki Nonaka, Shoichi Fukui, Tohru Michitsuji, Yushiro Endo, Ayako Nishino, Remi Sumiyoshi

Int J Rheum Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the safety profile of calcineurin inhibitors: cancer risk in patients with systemic lupus erythematosus from the LUNA registry-a historical cohort study.
Kunihiro Ichinose, Shuntaro Sato, Takashi Igawa, Momoko Okamoto, Ayuko Takatani, Remi Sumiyoshi

Arthritis Res Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The double shared epitope: Its impact on clinical features and ultrasound findings in rheumatoid arthritis.
Tohru Michitsuji, Shoichi Fukui, Ayako Nishino, Yushiro Endo, Kaori Furukawa, Remi Sumiyoshi

Int J Rheum Dis· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of 5-aminolevulinic acid in adult-onset Still's disease: A preclinical study in mice and a pilot study in humans.
Tomohiro Koga, Remi Sumiyoshi, Yoshika Tsuji, Ken Kodama, Yushiro Endo

Clin Immunol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the role of insulin-like growth factor binding protein-1 in identifying idiopathic multicentric Castleman's disease types: Implications for the mTOR signaling pathway.
Remi Sumiyoshi, Tomohiro Koga, Shoichi Fukui, Kaori Furukawa, Mamiko Momoki

Clin Immunol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis